These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 371887)
1. A placebo controlled clinical trial of transfer factor in lepromatous leprosy. Faber WR; Leiker DL; Nengerman IM; Schellekens PT Clin Exp Immunol; 1979 Jan; 35(1):45-52. PubMed ID: 371887 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862 [TBL] [Abstract][Full Text] [Related]
3. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules. Bapat CV; Modak MS; DeSouza NG; Chulawalla RG Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823 [TBL] [Abstract][Full Text] [Related]
5. Conversion of reactions to leprolin and lepromin in patients with lepromatous leprosy by the transfer factor. Han SH; Tsai LC; Hu SC; Loo ST Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):1-8. PubMed ID: 7004800 [TBL] [Abstract][Full Text] [Related]
6. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens. Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115 [TBL] [Abstract][Full Text] [Related]
7. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
11. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy. Nath I; Singh R Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396 [TBL] [Abstract][Full Text] [Related]
12. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. Convit J; Aranzazu N; Pinardi M; Ulrich M Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331 [TBL] [Abstract][Full Text] [Related]
13. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ; Kingston AE; Colston MJ Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217 [TBL] [Abstract][Full Text] [Related]
14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. Bullock WE; Fields JP; Brandriss MW N Engl J Med; 1972 Nov; 287(21):1053-9. PubMed ID: 4562439 [No Abstract] [Full Text] [Related]
16. Suppressor T lymphocytes from lepromatous leprosy skin lesions. Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration. Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597 [TBL] [Abstract][Full Text] [Related]
18. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278 [TBL] [Abstract][Full Text] [Related]
19. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
20. Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household. Menzel S; Bjune G; Kronvall G Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):138-52. PubMed ID: 378871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]